NovaBridge Biosciences

US$0.91As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:NBPHealthcare
Country USA
PE (Fwd) •••
TSR 7Y CAGR (31.93%)
Div yield —
ROE (59.10%)
Biotechnology
Beta (5Y) 1.72
PE TTM —
TSR TTM (81.63%)
Mkt cap US$105.5M
ROIC (833.39%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.10
21.22%
(60.64%)
Sell 5|5|3|9|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.02
6.73%
18.67%
16.01%
28.79%
Revenue$M
11.04
11.12
11.40
11.90
12.77%
7.92%
5.79%
7.22%
Peers (US$105.5M)
Cap (US$)
PE
105.7M
—
Capital
TTM
5Y
10Y
Leveragex
2.885
(0.051)
(0.054)
EBIT/Intx
0.507
4.311
3.605
Own earn%
(77.91)
(64.58)
(53.16)
Sh yield%
38.05
22.26
27.54
Owners
Insiders/Inst%
1.37
75.58
Short interest%
4.21
SBC / revenue%
0.66
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
21–24
$1 testx
−7.2
Incr. ROIC%
0